Sign In
Buy SNY
$44.38
+2.01 (+4.74%)
At Close: Jun 04, 2026
Sanofi looks to widen Dupixent use to treat 'smoker's lung' after second trial win
01:35am, Monday, 27'th Nov 2023
Sanofi plans to file for U.S. approval of wider use of its anti-inflammatory drug Dupixent against "smoker's lung", also known as COPD, after a second large trial showed significant benefits.
Mother of autistic children lodges complaint over emissions from Sanofi's Depakine drug plant -Le Monde
05:16am, Monday, 20'th Nov 2023
The mother of two autistic children in France has lodged a legal complaint for endangering life after she suspected she was exposed to airborne emissions from Sanofi's Depakine epilepsy drug plant, th
CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
08:44am, Friday, 17'th Nov 2023
The CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise in some parts of the country.
CDC releases 77,000 additional doses of Sanofi-AstraZeneca's RSV drug
02:19pm, Thursday, 16'th Nov 2023
The U.S. Centers for Disease Control and Prevention said on Thursday it has released more than 77,000 additional doses of Sanofi and AstraZeneca's respiratory syncytial virus (RSV) drug Beyfortus.
5 Dirt-Cheap Healthcare Stocks With Big Dividends To Buy Now
01:10pm, Saturday, 11'th Nov 2023
While many Wall Street firms are suggesting short Treasury paper and money markets now, for long-term investors looking for growth and income, healthcare is the place to be for the rest of 2023 and li
TEVA Q3 Earnings In Line, Sales Beat, Revenue View Raised
11:03am, Thursday, 09'th Nov 2023
TEVA reports decent third-quarter results. The company raises its revenue guidance for 2023 for the second time this year while keeping the EPS range intact.
French prosecutors investigating Sanofi over possible market manipulation
06:31am, Tuesday, 07'th Nov 2023
French prosecutors have opened a preliminary investigation into multinational pharmaceutical company Sanofi over possible market manipulation.
Pfizer and Sanofi shares fall, which one to scoop up?
06:18am, Tuesday, 07'th Nov 2023
Pharmaceutical stocks aren't having quite the banner year they've had in the past. Notably, two large pharmaceutical companies recently plunged to 52-week lows on their earnings results.
This Stock Just Dropped By 15%: Is It a Buy?
10:07am, Friday, 03'rd Nov 2023
Sanofi's third-quarter results weren't great, and the company announced a business separation. The biotech will lower its operating income margin target for 2025, which scared off many investors.
Investor patience tested as pharmaceutical stocks take a tumble
06:07am, Wednesday, 01'st Nov 2023
The Health Care Select Sector SPDR Fund NYSEARCA: XLV was down 3.81% in the past month and 8.03% in the past three months. The latest round of pharmaceutical stock earnings isn't helping sector perfor
MeiraGTx shares take off on $30M investment by Sanofi
11:43am, Monday, 30'th Oct 2023
MeiraGTx Holdings PLC (NASDAQ:MGTX) shares gained more than 25% after it announced Sanofi SA (ADR) (NYSE:SNY), a pharma giant best known for its vaccines, is purchasing 4 million of the gene company's
Sanofi stock recovers slightly after last week's plunge
11:39am, Monday, 30'th Oct 2023
Sanofi (SNY) shares are trending higher after plummeting last Friday, after the pharmaceutical company missed third-quarter earnings expectations, losing over $21 billion in market value. Sanofi annou
MeiraGTx shares jump as Sanofi invests in gene therapy
08:28am, Monday, 30'th Oct 2023
Shares of MeiraGTx Holdings PLC MGTX, -4.88% jumped 14% premarket on Monday after the gene therapy company announced that French drugmaker Sanofi SNY, -19.13% has made a $30 million investment.
Sanofi (SNY) Q3 2023 Earnings Call Transcript
02:26pm, Friday, 27'th Oct 2023
Sanofi (NASDAQ:SNY ) Q3 2023 Earnings Conference Call October 27, 2023 9:00 AM ET Company Participants Eva Schaefer-Jansen - Head of Investor Relations Paul Hudson - Chief Executive Officer Jean-Bapti
Sanofi (SNY) Beats on Q3 Earnings, to Spin-Off Consumer Unit
12:02pm, Friday, 27'th Oct 2023
Sanofi (SNY) beats third-quarter estimates for earnings but misses the same for sales. It announces plans to separate its Consumer unit into a new public listed company.
